Asfia Sultana

Asfia Sultana

Auto-generated profile, based on publicly available information

Asfia Sultana

College of Health & Life Sciences, Hamad Bin Khalifa University, Doha, Qatar

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Open access
WAWesam S. Ahmed
Wesam S. Ahmed
AGAnupriya M. Geethakumari
Anupriya M. Geethakumari
ASAsfia Sultana
Asfia Sultana
AFAsma Fatima
Asma Fatima
APAngelin Mary Philip
Angelin Mary Philip
KBKabir H Biswas
Kabir H Biswas
NanoLuc (NLuc) luciferase has found extensive application in designing a range of biological assays, including gene expression analysis, protein-protein interaction, and protein conformational changes due to its enhanced brightness and small size. However, questions related to its mechanism of interaction with the substrate, furimazine, as well as bioluminescence activity remain elusive. Here, we combined molecular dynamics (MD) simulation and mutational analysis to show that the R162A mutation results in a decreased but stable bioluminescence activity of NLuc in living cells and in vitro. Specifically, we performed multiple, all-atom, explicit solvent MD simulations of the apo and furimazine-docked (holo) NLuc structures revealing differential dynamics of the protein in the absence and presence of the ligand. Further, analysis of trajectories for hydrogen bonds (H-bonds) formed between NLuc and furimazine revealed substantial H-bond interaction between R162 and Q32 residues. Mutation of the two residues in NLuc revealed a decreased but stable activity of the R162A, but not Q32A, mutant NLuc in live cell and in vitro assays performed using lysates prepared from cells expressing the proteins and with furimazine substrate. In addition to highlighting the role of the R162 residue in NLuc activity, we believe that the mutant NLuc will find wide application in designing in vitro assays requiring extended monitoring of NLuc bioluminescence activity. SIGNIFICANCE: Bioluminescence has been extensively utilized in developing a variety of biological and biomedical assays. In this regard, engineering of brighter bioluminescent proteins, i.e. luciferases, has played a significant role. This is acutely exemplified by the engineering of the NLuc luciferase, which is small in size and displays much enhanced bioluminescence and thermal stability compared to previously available luciferases. While enhanced bioluminescent activity is desirable in a multitude of biological and biomedical assays, it would also be useful to develop variants of the protein that display a prolonged bioluminescence activity. This is specifically relevant in designing assays that require bioluminescence for extended periods, such as in the case of biosensors designed for monitoring slow enzymatic or cellular signaling reactions, without necessitating multiple rounds of luciferase substrate addition or any specialized reagents that result in increased assay costs. In the current manuscript, we report a mutant NLuc that possesses a stable and prolonged bioluminescence activity, albeit lower than the wild-type NLuc, and envisage a wider application of the mutant NLuc in designing biosensors for monitoring slower biological and biomedical events.

7 August 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
WAWesam S. Ahmed
Wesam S. Ahmed
AGAnupriya M Geethakumari
Anupriya M Geethakumari
ASAsfia Sultana
Asfia Sultana
ATAnmol Tiwari
Anmol Tiwari
Tausif AltamashTausif Altamash
Tausif Altamash
KBKabir H Biswas
Kabir H Biswas
Ligand binding to GAF domains regulates the activity of associated catalytic domains in a wide variety of proteins. For instance, cGMP binding to the GAFa domain of phosphodiesterase 5 (PDE5) activates the cGMP-hydrolyzing catalytic domain in the protein. However, the residues involved and the mechanism of GAF domain function are not entirely clear. Here, combining computational and experimental analysis, we show that two highly coevolving residues distant from the ligand binding site play a critical role in GAF domain allostery. Specifically, Statistical Coupling Analysis (SCA) of GAF domain sequences revealed the highest coevolution score for residues L267 and F295. Molecular dynamics (MD) simulations of both apo and holo forms of the wild type and mutant (L267A and F295A) PDE5 GAFa domains revealed significant alterations in structural dynamics and interaction with cGMP. Incorporation of the mutations in a Bioluminescence Resonance Energy Transfer (BRET)-based biosensor, which reports a ligand-induced conformational change, revealed a change in the conformation of the GAF domain and an increase in the EC 50 of cGMP-induced conformational change. Similar results were obtained regarding cGMP-induced conformational change in the full-length PDE5 and in the fluorescence of the GAF domain fluorescent protein, miRFP670nano3. Finally, structural analysis of conformers observed in MD simulations revealed a possible mechanism underlying the impact of mutations of these two coevolving residues in the PDE5 GAFa domain. Our results provide insight into the role of distant, coevolving residues in GAF domain allostery, and may aid in understanding evolution of allostery in proteins.

26 August 2026 in Journal of Biological Chemistry
Verified
Journal Article
Open access
AFAsma Fatima
Asma Fatima
AGAnupriya M. Geethakumari
Anupriya M. Geethakumari
ASAsfia Sultana
Asfia Sultana
SUS M NASIR UDDIN
S M NASIR UDDIN
ZEYAUL ISLAMZEYAUL ISLAM
ZEYAUL ISLAM
KBKabir H Biswas
Kabir H Biswas

21 May 2026 in Analytical Biochemistry
Verified
Journal Article
Closed access
ASAsfia Sultana
Asfia Sultana
AGAnupriya M. Geethakumari
Anupriya M. Geethakumari
KBKabir H Biswas
Kabir H Biswas